Kalydeco

Generic name: Ivacaftor
Drug class: CFTR potentiators

Usage of Kalydeco

Kalydeco is used to treat cystic fibrosis in adults and children who are at least 1 month old and weigh at least 6 pounds (3 kilograms).

Kalydeco tablets can be used in children aged 6 years and older. Kalydeco granules can be used in children aged 1 month to under 6 years old.

Cystic fibrosis is an inborn disease that causes problems with breathing, digestion, and reproduction) in adults and children 1 month of age and older.

Kalydeco should be used only in people with a specific gene mUTAtion related to cystic fibrosis. Your doctor may order a blood test to help decide if this medication is right for you.

Kalydeco belongs to a class of medications called cystic fibrosis transmembrane conductance regulator (CFTR) potentiators. Ivacaftor works by improving the function of a protein in the body to decrease the build-up of thick mucus in the lungs and improving other symptoms of cystic fibrosis.

Kalydeco side effects

Get emergency medical help if you have signs of an allergic Reaction to Kalydeco: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Kalydeco may cause serious side effects. Call your doctor at once if you have:

blurred vision, eye pain or redness, seeing halos around lights;

low blood sugar--headache, hunger, weakness, sweating, confusion, irritability, dizziness, fast heart rate, or feeling jittery; or

liver problems - loss of appetite, nausea, vomiting, stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Common Kalydeco side effects may include:

muscle or joint pain;

dizziness;

rash, acne;

headache;

mouth pain;

stomach pain, nausea, diarrhea; or

cold symptoms such as stuffy nose, sneezing, runny nose, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Kalydeco

You should not be treated with Kalydeco if you are allergic to ivacaftor.

To make sure Kalydeco is safe for you, tell your doctor if you have ever HAD:

liver or kidney disease.

It is not known if ivacaftor will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Ask a doctor if it is safe to breastfeed while using Kalydeco.

Relate drugs

How to use Kalydeco

Usual Adult Dose for Cystic Fibrosis:

150 mg orally every 12 hours with fat containing food Comments: -Examples of fat-containing food include: eggs, butter, peanut butter, cheese pizza, and whole milk dairy products. -If the patient's genotype is unknown, an approved CF mutation test should be used to detect the presence of a CFTR mutation followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use. Uses: -For the treatment of cystic fibrosis in patients having one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data.

Usual Pediatric Dose for Cystic Fibrosis:

Oral Granules: Age: 4 months to less than 6 months: Weight: 5 kg or greater: 25 mg orally every 12 hours -Use is not recommended in the presence of hepatic impairment or in those taking concomitant moderate or strong CYP450 3A inhibitors Age: 6 months or older: Weight: 5 to less than 7 kg: 25 mg orally every 12 hours Weight: 7 to less than 14 kg: 50 mg orally every 12 hours Weight: 14 kg or greater: 75 mg orally every 12 hours Oral Tablet: Age: 6 years and older: 150 mg orally every 12 hours Comments: -Doses should be taken just before or after fat-containing food; examples of fat-containing food include: eggs, butter, peanut butter, cheese pizza, and whole milk dairy products. -Dose adjustments are recommended for patients 6 months or older with hepatic impairment and/or taking concomitant moderate or strong CYP450 3A inhibitors. -If the patient's genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of a CFTR mutation followed by verification with bi-directional sequencing when recommended by the mutation test instructions for use. Uses: -For the treatment of cystic fibrosis in patients 4 months or older having one mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data.

Warnings

Before you take Kalydeco, tell your doctor if you have liver or kidney disease.

Kalydeco should be taken with a food that contains fat, such as butter, peanut butter, eggs, cheese pizza, or whole-milk dairy products such as whole milk, cheese, and yogurt. Follow your doctor's instructions very carefully.

Grapefruit, grapefruit juice, and Seville oranges may interact with Kalydeco and lead to unwanted effects. Discuss the use of grapefruit and orange products with your doctor.

To be sure Kalydeco is not causing harmful effects, your liver function will need to be checked with frequent blood tests. Visit your doctor regularly.

There are many other drugs that can interact with ivacaftor. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor. Keep a list of all your medicines and show it to any healthcare provider who treats you.

What other drugs will affect Kalydeco

Sometimes it is not safe to use certain medicines at the SAMe time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.

Tell your doctor about all your other medicines, especially:

St. John's wort;

seizure medicine such as Carbamazepine, phenobarbital, or phenytoin;

an antibiotic - clarithromycin, erythromycin, Telithromycin, rifabutin, rifampin; or

antifungal medicine - fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole.

This list is not complete. Other drugs may interact with ivacaftor, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.